Clinical Trials
-
Principal Investigator:
Michael T Yin, MDWe are conducting a research study to see if hormone therapy (HT) helps reduce hot flashes and night sweats in women living with HIV in the late menopausal transition (similar to what is known as perimenopause) or early post-menopause (the time after the final menstrual period or after removal of both ovaries). If you were assigned female sex at birth, are 40-60 years old, are in the late menopausal transition or early post-menopause, currently having moderate to severe hot flashes and night sweats at least every week, and you are living with HIV, you may qualify to participate in this... -
Principal Investigator:
Magdalena E Sobieszczyk, MD, MPHWe are looking for individuals over 18 years old who are interested in learning more about COVID-19 prevention research studies. We will ask you to complete a brief questionnaire to find out if you may be eligible for one of our studies. We can then schedule a phone call, teleconference, or in-person education visit so you can learn about the research we do and decide if you want to participate in one of our studies. Your responses to this questionnaire will be kept strictly confidential. -
Principal Investigator:
Magdalena E Sobieszczyk, MD, MPHDo you identify as a woman or transgender person, or do you have a non-binary gender identity? Has a medical provider ever diagnosed you with a sexually transmitted infection or recommended PrEP/another HIV prevention method? We are conducting a study to understand attitudes and preferences regarding HIV prevention methods among people who do not have HIV. The study involves taking online surveys. Some surveys are compensated. Please reach out if you are interested in hearing more about the study. -
Principal Investigator:
Deborah A Theodore, MDThis is a study for people with symptoms of long COVID. We are looking for people over the age of 18 who are interested in participating in a study to understand whether a mindfulness meditation intervention can help improve symptoms of long COVID. Study participation lasts 6 months and is fully remote.